Microbot Medical (NASDAQ:MBOT) & CVR Medical (OTCMKTS:CRRVF) Head to Head Review

CVR Medical (OTCMKTS:CRRVF) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for CVR Medical and Microbot Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
Microbot Medical	0	0	1	0	3.00

Microbot Medical has a consensus price target of $7.00, suggesting a potential upside of 274.33%. Given Microbot Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than CVR Medical.

Valuation and Earnings

This table compares CVR Medical and Microbot Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	-$1.82 million	N/A	N/A
Microbot Medical	N/A	N/A	-$10.74 million	($0.80)	-2.34

Profitability

This table compares CVR Medical and Microbot Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
Microbot Medical	N/A	-218.30%	-158.17%

Insider & Institutional Ownership

16.3% of Microbot Medical shares are held by institutional investors. 10.5% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Microbot Medical beats CVR Medical on 5 of the 8 factors compared between the two stocks.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About Microbot Medical

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.